MIR3939

Across TCGA pan-cancer cohorts, MIR3939 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR3939 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR3939 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR3939 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

KIRC, UCS, and SARC are the cancer types where MIR3939 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.853	0.754	<.001	118	view →
UCS	OS	Tertile	All	0.383	0.631	.019	54	view →
SARC	DFS	Tertile	All	0.259	0.520	.007	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
LGG	OS	Tertile	All	0.693	0.865	.003	15	view →
THCA	OS	Tertile	All	0.681	0.970	.018	12	view →
HNSC	OS	Tertile	IV	0.291	0.535	.049	6	view →
KICH	DFS	Tertile	II,III,IV	0.436	0.906	.017	5	view →
SKCM	OS	Tertile	IV	1.000	0.314	.030	3	view →
THYM	DFS	Quartile	All	0.749	0.955	.048	1	view →
COAD	OS	Quartile	II,III,IV	0.773	0.863	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR3939–KIRC (OS)

Open the KIRC breakdown →